Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Vestibulum tortor quam, feugiat vitae, ultricies eget, tempor sit amet, ante. Donec eu libero sit amet quam egestas semper. Aenean ultricies mi vitae est. Mauris placerat eleifend leo. Etiam sapien elit, consequat eget, tristique non, venenatis quis, ante. Mauris tincidunt sem sed arcu. Nunc auctor. Mauris dictum facilisis augue. Phasellus faucibus molestie nisl. Nullam dapibus fermentum ipsum. Aliquam erat volutpat. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab
Top pants upper
Related products
-
Add to cartFeature Specification Details Active Ingredient Tirzepatide (Dual GIP / GLP-1 Receptor Agonist) Bundle Contents 1 x 2.5mg KwikPen (4 doses) + 1 x 5mg KwikPen (4 doses) Total Duration 8 Weeks of continuous medical treatment Administration Route Subcutaneous injection (Once weekly) Storage Protocols Refrigerate at 2°C – 8°C; Unrefrigerated stable up to 30 days below 30°C Target Indications Chronic weight management, metabolic support, and obesity care -
Select options This product has multiple variants. The options may be chosen on the product pageThis is a variable product.
Etiam bibendum elit eget erat. Curabitur bibendum justo non orci. Cras elementum. In dapibus augue non sapien. Morbi imperdiet, mauris ac auctor dictum, nisl ligula egestas nulla, et sollicitudin sem purus in lacus. Praesent dapibus.
-
Select options This product has multiple variants. The options may be chosen on the product page
This is a variable product.
Pellentesque arcu. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Sed elit dui, pellentesque a, faucibus vel, interdum nec, diam. Pellentesque ipsum. Etiam dui sem, fermentum vitae, sagittis id, malesuada in, quam. Sed ac dolor sit amet purus malesuada congue.
-
Add to cartAttribute Specification Product Name Mounjaro Bundles (Maintenance & Escalation Phase) Available Strengths 5mg / 0.5mL and 7.5mg / 0.5mL Active Ingredient Tirzepatide (Dual GIP and GLP-1 Receptor Agonist) Administration Route Subcutaneous Injection (Once-Weekly) Primary Indication Chronic Weight Management & Type 2 Diabetes Adjunct Packaging Configuration Multi-dose pre-filled injection pens (4-week supply per strength) Storage Requirements Refrigerated storage ($2^\circ\text{C}$ to $8^\circ\text{C}$), do not freeze -
Add to cartProduct Parameter Details Product Name Mounjaro 12.5mg Active Ingredient Tirzepatide (12.5 mg per 0.6 mL dose) Drug Class GIP and GLP-1 Receptor Agonist (Dual Incretin Mimetic) Primary Indication Chronic Weight Management & Type 2 Diabetes Treatment Administration Route Subcutaneous Injection (Once-Weekly) Manufacturer Eli Lilly Storage Requirements Refrigerate between 2°C to 8°C; Do not freeze